Professor Gerry Hanna

Professor Gerry Hanna is the Marie Curie Chair of Clinical Oncology at Trinity College Dublin and a Consultant in Radiation Oncology at the St Lukes Radiation Oncology Network within the Trinity St James Cancer Institute. Gerry also holds honorary appointments at the University of Melbourne, and Queen’s University Belfast.

His Research interests include the use of PET/CT in radiotherapy planning for lung cancer, mechanisms of radiotherapy resistance, stereotactic ablative radiotherapy and systemic therapy and immunotherapy combinations with radiotherapy.

Prof Hanna is the Vice-Clinical Lead of Cancer Trials Ireland, Chief Investigator of the Peter Mac ACRF Radiation Immuno-oncology Program and the International Atomic Energy Agency’s “PERTAIN” study. He is the former chief investigator and current TMG member of the CRUK funded CONCORDE study. Gerry is also a TMG member for the UK’s HALT, SARON, CONFIRM and ISOTOXIC IMRT studies and continues to provide research support to Belfast Trust.